NAFION(TM) 350(170006-88-9)
- Name: NAFION(TM) 350
- Synonyms:NAFION(TM) 350;nafion 350;Nafion?350;NAFION 350, PERFLUORINATED MEMBRANE, RE- INFORCED WITH TEFLON, 0.01IN. THICK;Nafion(R) 350
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:170006-88-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.170006-88-9 NAFION(TM) 350
Assay:99% Package:According to customer requirements Transportation:By Sea/Air/Courier Application:medicine
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.170006-88-9 NAFION(TM) 350
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.170006-88-9 NAFION(TM) 350
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:NAFION(TM) 350
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.170006-88-9 NAFION 350, PERFLUORINATED MEMBRANE, RE- INFORCED WITH TEFLON, 0.01IN. THICK
Assay:97% Appearance:Powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 170115-96-5/(S,S)-(+)-PSEUDOEPHEDRINE GLYCINAMIDE
- 170114-51-9/2H-Pyran-2,4-diol,tetrahydro-6-(1-methylethyl)-,[2S-(2alpha,4alpha,6bta)]-(9CI)
- 170114-50-8/2H-Pyran-2,4-diol,tetrahydro-6-(1-methylethyl)-,[2R-(2alpha,4bta,6alpha)]-(9CI)
- 170099-04-4/2(1H)-Quinoxalinone,7-fluoro-3,4-dihydro-6-methyl-(9CI)
- 170097-67-3/2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-6-CARBOXYLIC ACID
- 170097-66-2/2-TERT-BUTYL 6-METHYL 3,4-DIHYDROISOQUINOLINE-2,6(1H)-DICARBOXYLATE
- 170082-80-1/Methyl pentyl methylphosphonate
- 170082-15-2/CLONAZEPAM-D4
- 170081-43-3/tert-Butyl-dimethyl-{3-[7a-methyl-1-(1,4,5-trimethyl-hex-2-enyl)-octahydro-inden-4-ylidenemethyl]-2,2-dioxo-2,3,4,5,6,7-hexahydro-1H-2l6-benzo[c]thiophen-5-yloxy}-silane
- 170080-85-0/3-Cyclohexene-1-carbonyl chloride, 4-methyl-, (S)- (9CI)
- 170080-38-3/Carbamic acid, [1-(1-methylethyl)-2-butenyl]-, 1,1-dimethylethyl ester, (S)-
- 170078-65-6/2,3-DI-O-BENZYL-4,6-O-ETHYLIDENE-BETA-D-GLUCOPYRANOSE
- 170078-14-5/3,5-Dioxa-8-azabicyclo[5.1.0]octane,4-(1-methylethyl)-,(1alpha,4bta,7alpha)-(9CI)
- 170026-03-6/[746581-25-9], C7H10N2O2,138.08
- 170023-67-3/N6-(DIISOBUTYLAMINOMETHYLIDENE)-5'-O-(DIMETHOXYTRITYL)-O2-(DIPHENYLCARBAMOYL )-2'-DEOXYISOGUANOSINE
- 170012-71-2/L-Proline, (4R)-4-hydroxy-5-oxo-, methyl ester (9CI)
- 170006-88-9/NAFION(TM) 350
- 169949-53-5/4-Pyridinepropanoicacid,-alpha--amino-2-cyano-,(S)-(9CI)
- 169908-52-5/4-Thiazolidinecarboxylicacid,2-(1-methylethyl)-,(2S-trans)-(9CI)
- 169908-35-4/4-Thiazolidinecarboxylicacid,2-(1-methylethyl)-,(2R-cis)-(9CI)
- 169908-09-2/2,4-Azetidinedimethanol, 1-acetyl-, cis- (9CI)
- 169908-06-9/3,3-Azetidinedimethanol, 1-acetyl- (9CI)
- 169905-05-9/2H-Benzimidazole-2-thione,4,6-difluoro-1,3-dihydro-(9CI)
- 169905-00-4/2-[(4-ETHOXY-3-METHYL-2-PYRIDINYL)-METHYLSULFINYL]-BENZIMIDAZOLE
- 169899-25-6/Cyclohexene, 4-(difluoromethylene)-5-fluoro-, (S)- (9CI)
- 169899-24-5/Cyclohexene, 4-(difluoromethylene)-5-fluoro-, (R)- (9CI)
- 169899-15-4/2-((FURAN-2-YL)METHYLSULFINYL)-N-((Z)-4-HYDROXYBUT-2-ENYL)ACETAMIDE
- 169889-24-1/2H-Azirine-2-carboxylicacid,3-propyl-,methylester,(R)-(9CI)
- 169888-58-8/[1,2,3]Triazolo[1,5-a]pyridine-7-carboxaldehyde (9CI)
- 169888-53-3/Isoxazole, 5-(dichloromethyl)- (9CI)